SlideShare une entreprise Scribd logo
1  sur  50
2ND YEAR MEDICAL STUDENTS
MODULE IX
BY
DR. HAZEM ABO SHOUSHA
Main rules
•ABP: pressure of blood on arterial wall
ABP= COP X PVR
COP= HR X SV
Main rules
HEART RATE
Main rules
Main rules
β1 Agonist M2 blocker
β1 blocker M2 agonist
HEART RATE
Main rules
BLOOD VESSELS
α1
β2
M3
Main rules
BLOOD PRESSURE (Bl.V)
VC
α1 agonist
β2 blocker
VD
α1 blocker
β2 agonist
M3 agonist
Main rules
BARORECEPTORS
VD
VC
NORADRENALINE
1 1
Observation: increased ABP with minimal effect on HR, which increases only with high doses
Explanation of effect of NE on ABP & HR:
 NE acts mainly on 1 receptors  vasoconstriction PVR
 With higher doses of NE, it activates also cardiac 1 receptors some increase in the heart
rate
PRAZOSIN
1 blocker
What is the effect of Prazosin on ABP and HR?
•it blocks 1 adrenoceptors  vasodilationPVRABP
•ABP slight reflex tachycardia
Noradrenaline cause very minimal  in HR  β1 stimulation minimal  in BP
1 β1 β2
ADRENALINE
Observation:  ABP & HR
late The ABP  before returning to base line level
Explanation of the effect of epinephrine on HR & ABP
Epinephrine stimulates 1 , 1, 2 adrenoceptors Beta receptors are more sensitive to the effect of epinephrine
On heart: 1 activation  +ve inotropic & chronotropic effects  COP leading to increased
ABP
On BV :
- 1 activation vasoconstriction  PVR.
- 2 activation vasodilatation  PVR
•The net effect of these two opposing effects (1 & 2 )
on bl.v is an in  PVR
(1 wins at 1st )
•At High concentration:
EPI stimulates 1
•At Low concentration:
EPI stimulates 2
AdrenalineNoradrenalineparameters
More increaseMild or no increaseHeart rate
Less increase than
noradrenaline
More increaseBlood pressure
BP decreases before
reaching base line
Reach base line directlyBP before Base line
β1 blocker
Cardioselective beta blocker
ATENOLOL
Observation: blocking 1 receptors by atenolol blocks
the effect of epinephrine on HR & decreases the effect
on ABP
block alpha1 & beta1 receptors & then inject epinephrine
EPINEPHRINE REVERSAL:
The presser effect of epinephrine is reversed due to
1 & 1 blockade, leaving the 2 vasodilating effect acting 
 ABP
β1 + β2 blocker
Non-selective beta blocker
PROPRANOLOL
How to confirm the cause of epinephrine reversal?
No epinephrine reversal since propranolol blocks not only cardiac 1 receptors but also vascular
2 receptors
What is the effect of propranolol on ABP and HR?
Propranolol mechanism as antihypertensive:
1-Block β1 in heart so low COP BP
2-  central sympathetic discharge  BP
3- Block β1 in kidney Renin  BP
4- resetting of Baroreceptors  BP
5- Block β2 presynaptic NE release  BP
β1 + β2 agonist
Non-selective beta agonist
ISOPRENALINE
Observation:
• Isoprenaline increases HR
• Isoprenaline initially decreases ABP.
• As HR reaches its maximum increase, ABP shows minimal increase before returning to normal
Explanation for the effect of isoprenaline on HR & ABP
• Isoprenaline activates mainly beta adrenoceptor
• It activates cardiac 1 receptors leading to increase in HR & force of contraction
(which increases COP)
• Activation of 2 receptors—Vasodilation decrease in PVR
• The net effect of the two factors (COP & PVR) is a decrease in blood pressure
initially.
• However, when force of contraction is markedly elevated, the increase of COP
overcomes the effect of decrease in PVR and thus ABP starts to increase.
Design an experiment to prove the explanation for the effect of Isoprenaline on
HR & ABP
Observation: atenolol abolishes the effect of
isoprenaline on HR
The initial ABP-lowering effect of isoprenaline is
maintained, while its pressor effect is abolished
PROPRANOLOL FOLLOWED BY ISOPRENALINE
Observation: Propranolol blocks 1 & 2 receptors thus abolishes the
effect of isoprenaline on ABP
1 agonist
selective Alpha agonist
PHENYLEPHRINE
Observation:
Small dose phenylephrine leads to slight increase in ABP with no effect on HR
High dose phenylephrine increases markedly ABP with decrease in the HR ( reflex bradycardia)
Explanation of the effect of phenylephrine on ABP & HR
•Activation of 1 receptors  vasoconstrictionPVR
•High dose of phenylephrine  marked elevation of ABP 
reflex  in sympathetic activity. Parasympathetic activity will
take the upper hand  HR
prove the explanation of the effect of phenylephrine on HR
and ABP
Observation: prazosin abolishes the effect of phenylephrine
on ABP & reflex bradycardia disappears
prove that reflex bradycardia is due to relative
increase in parasympathetic activity
Observation: decreased HR is abolished by atropine despite of elevation of ABP
Nicotinic
Nn , Nm
ACETYLCHOLINE ( Ach )
Muscarinic
M1 , M2 ,M3
Observation:
small doses of acetylcholine lower only ABP
Higher doses produce both  in the HR & more
significant lowering of ABP
Explanation for the effect of
acetylcholine on HR and ABP
•on heart: M2 activation  - ve chronotropic effect  COP
•on BV: endothelial cells M3 activation  release of NO from vascular
endothelial cells  vasodilatation  PVR
• Decrease in heart rate & decrease in PVR lead to  ABP
Inject ATROPINE & then test the effect of ACETYLCHOLINE
ACETYLCHOLINE REVERSAL
1. Inject a test dose of Ach
2. Inject atropine
3.Inject the same dose of acetylcholine
4.Inject a dose of Ach which is 10 times the test dose
Explanation for acetylcholine reversal
• Atropine injection  A parasympatholytic blocks muscarinic receptors. It blocks
the effect of small dose of Ach.
• Ach injection [big dose]  Stimulates nicotinic receptors Nn after muscarinic
receptors have been blocked by atropine   ABP
• Due to activation of Nn at :
• Adrenal medulla  release epinephrine  BP
• Autonomic ganglia  release of catecholamines from post-synaptic adrenergic nerve endings
 BP
• The BP by Ach [big dose] after muscarinic receptor block [by atropine]
 Ach reversal
oAch reversal by : Nn receptors
oEPI reversal by : β2 receptors
Reversible
anticholinesterase
So  Ach ‘ ’augment Ach effect ‘ ’
NEOSTIGMINE
prove the mechanism of action of neostigmine
Practical pharmacology CNS

Contenu connexe

Tendances

Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonistsLeul Mesfin
 
Ionotropes and vasopressor use in the ED
Ionotropes and vasopressor use in the EDIonotropes and vasopressor use in the ED
Ionotropes and vasopressor use in the EDSCGH ED CME
 
Vasopressors And Inotropes
Vasopressors And InotropesVasopressors And Inotropes
Vasopressors And InotropesAndrew Ferguson
 
Vasopressors and inotropes
Vasopressors and inotropesVasopressors and inotropes
Vasopressors and inotropesJason Begalke
 
adrenergic drugs
adrenergic drugsadrenergic drugs
adrenergic drugsNasir Koko
 
Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter yehiamatter
 
Inotropes & vasopressors
Inotropes & vasopressorsInotropes & vasopressors
Inotropes & vasopressorsdocshashank
 
Vassopressors and Inotropes
Vassopressors and InotropesVassopressors and Inotropes
Vassopressors and InotropesRunal Shah
 
Locke vasopressor ppt
Locke vasopressor pptLocke vasopressor ppt
Locke vasopressor pptBrian Locke
 
Anti adrenergic drugs
Anti adrenergic drugsAnti adrenergic drugs
Anti adrenergic drugsJegan Nadar
 
Sympathomimetics- pharmacology
Sympathomimetics- pharmacologySympathomimetics- pharmacology
Sympathomimetics- pharmacologyDHINESHKUMAR V
 
Adrenergic drugs 2017
Adrenergic drugs 2017Adrenergic drugs 2017
Adrenergic drugs 2017Pravin Prasad
 
Shock And Vasoactive Drugs
Shock And Vasoactive DrugsShock And Vasoactive Drugs
Shock And Vasoactive DrugsMuhammad Badawi
 

Tendances (20)

Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonists
 
Ionotropes and vasopressor use in the ED
Ionotropes and vasopressor use in the EDIonotropes and vasopressor use in the ED
Ionotropes and vasopressor use in the ED
 
Vasoconstrictors
VasoconstrictorsVasoconstrictors
Vasoconstrictors
 
Vasopressors And Inotropes
Vasopressors And InotropesVasopressors And Inotropes
Vasopressors And Inotropes
 
Vasopressors in icu
Vasopressors in icuVasopressors in icu
Vasopressors in icu
 
pharmacology
pharmacologypharmacology
pharmacology
 
Inotropes by elza
Inotropes by elzaInotropes by elza
Inotropes by elza
 
Vasopressors and inotropes
Vasopressors and inotropesVasopressors and inotropes
Vasopressors and inotropes
 
adrenergic drugs
adrenergic drugsadrenergic drugs
adrenergic drugs
 
Vasoactve drugs
Vasoactve  drugsVasoactve  drugs
Vasoactve drugs
 
Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter
 
Inotropes & vasopressors
Inotropes & vasopressorsInotropes & vasopressors
Inotropes & vasopressors
 
Ionotrops 3
Ionotrops 3Ionotrops 3
Ionotrops 3
 
Vassopressors and Inotropes
Vassopressors and InotropesVassopressors and Inotropes
Vassopressors and Inotropes
 
inotropes 2
inotropes 2inotropes 2
inotropes 2
 
Locke vasopressor ppt
Locke vasopressor pptLocke vasopressor ppt
Locke vasopressor ppt
 
Anti adrenergic drugs
Anti adrenergic drugsAnti adrenergic drugs
Anti adrenergic drugs
 
Sympathomimetics- pharmacology
Sympathomimetics- pharmacologySympathomimetics- pharmacology
Sympathomimetics- pharmacology
 
Adrenergic drugs 2017
Adrenergic drugs 2017Adrenergic drugs 2017
Adrenergic drugs 2017
 
Shock And Vasoactive Drugs
Shock And Vasoactive DrugsShock And Vasoactive Drugs
Shock And Vasoactive Drugs
 

En vedette

Qcl 15-v4 [5]-[iift]_[pranjal_parihar]
Qcl 15-v4 [5]-[iift]_[pranjal_parihar] Qcl 15-v4 [5]-[iift]_[pranjal_parihar]
Qcl 15-v4 [5]-[iift]_[pranjal_parihar] Pranjal Parihar
 
PVRs - Less talk and more action
PVRs - Less talk and more actionPVRs - Less talk and more action
PVRs - Less talk and more actionRichard Huntington
 
PVR Investor Presentation - August 2016
PVR Investor Presentation - August 2016PVR Investor Presentation - August 2016
PVR Investor Presentation - August 2016Pranav Rao
 
Rapid development of pvr cinemas
Rapid development of pvr cinemasRapid development of pvr cinemas
Rapid development of pvr cinemasDeepak Raj
 
Entertainment updated
Entertainment updatedEntertainment updated
Entertainment updatedROBIN HUYAM
 
SIP Final Report By Niraj Thakur
SIP Final Report By Niraj ThakurSIP Final Report By Niraj Thakur
SIP Final Report By Niraj ThakurNiraj Thakur
 
customer's prefrences for multiplexes in lucknow
customer's prefrences for multiplexes in lucknowcustomer's prefrences for multiplexes in lucknow
customer's prefrences for multiplexes in lucknowSACHIN AWASTHI
 
Value Chain Analysis of PVR Ltd.
Value Chain Analysis of PVR Ltd.Value Chain Analysis of PVR Ltd.
Value Chain Analysis of PVR Ltd.jaaneaditi
 
Final copy pvr
Final copy pvrFinal copy pvr
Final copy pvramoljun
 
PVR CINEMAS-Service marketing
PVR CINEMAS-Service marketingPVR CINEMAS-Service marketing
PVR CINEMAS-Service marketingjojisj
 
Introduction to cns pharmacology
Introduction to cns pharmacologyIntroduction to cns pharmacology
Introduction to cns pharmacologyFarazaJaved
 
Reversal action of adrenaline on blood pressure in dog
Reversal action of adrenaline on blood pressure in dogReversal action of adrenaline on blood pressure in dog
Reversal action of adrenaline on blood pressure in dogSameh Abdel-ghany
 

En vedette (18)

Qcl 15-v4 [5]-[iift]_[pranjal_parihar]
Qcl 15-v4 [5]-[iift]_[pranjal_parihar] Qcl 15-v4 [5]-[iift]_[pranjal_parihar]
Qcl 15-v4 [5]-[iift]_[pranjal_parihar]
 
Ten provocations
Ten provocationsTen provocations
Ten provocations
 
PVRs - Less talk and more action
PVRs - Less talk and more actionPVRs - Less talk and more action
PVRs - Less talk and more action
 
PVR Investor Presentation - August 2016
PVR Investor Presentation - August 2016PVR Investor Presentation - August 2016
PVR Investor Presentation - August 2016
 
Rapid development of pvr cinemas
Rapid development of pvr cinemasRapid development of pvr cinemas
Rapid development of pvr cinemas
 
Entertainment updated
Entertainment updatedEntertainment updated
Entertainment updated
 
Pvr
PvrPvr
Pvr
 
SIP Final Report By Niraj Thakur
SIP Final Report By Niraj ThakurSIP Final Report By Niraj Thakur
SIP Final Report By Niraj Thakur
 
May 2012 - PVR Ltd (Multibagger Stock Pick)
May 2012 - PVR Ltd (Multibagger Stock Pick)May 2012 - PVR Ltd (Multibagger Stock Pick)
May 2012 - PVR Ltd (Multibagger Stock Pick)
 
customer's prefrences for multiplexes in lucknow
customer's prefrences for multiplexes in lucknowcustomer's prefrences for multiplexes in lucknow
customer's prefrences for multiplexes in lucknow
 
Value Chain Analysis of PVR Ltd.
Value Chain Analysis of PVR Ltd.Value Chain Analysis of PVR Ltd.
Value Chain Analysis of PVR Ltd.
 
Final copy pvr
Final copy pvrFinal copy pvr
Final copy pvr
 
PVR CINEMAS-Service marketing
PVR CINEMAS-Service marketingPVR CINEMAS-Service marketing
PVR CINEMAS-Service marketing
 
Introduction to cns pharmacology
Introduction to cns pharmacologyIntroduction to cns pharmacology
Introduction to cns pharmacology
 
Adrenergic agonists & antagonists in veterinary medicine
Adrenergic agonists & antagonists in veterinary medicine Adrenergic agonists & antagonists in veterinary medicine
Adrenergic agonists & antagonists in veterinary medicine
 
L7
L7L7
L7
 
The Power of Color in Branding
The Power of Color in BrandingThe Power of Color in Branding
The Power of Color in Branding
 
Reversal action of adrenaline on blood pressure in dog
Reversal action of adrenaline on blood pressure in dogReversal action of adrenaline on blood pressure in dog
Reversal action of adrenaline on blood pressure in dog
 

Similaire à Practical pharmacology CNS

Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptxZainAliKhan17
 
SYMPATHOMIMETICS AND LYTICS .pptx
SYMPATHOMIMETICS AND LYTICS .pptxSYMPATHOMIMETICS AND LYTICS .pptx
SYMPATHOMIMETICS AND LYTICS .pptxSBiswajit
 
INOTROPES IN SHOCK.pptx
INOTROPES IN SHOCK.pptxINOTROPES IN SHOCK.pptx
INOTROPES IN SHOCK.pptxElakiya28
 
7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt7.Adrenergic agonists.ppt
7.Adrenergic agonists.pptssuser7b172e
 
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. PawanPharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. PawanDr. Pawan Kumar B
 
adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonistsdrjawaria73
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxayman255825
 
Inotropes and vasopressors
Inotropes and vasopressorsInotropes and vasopressors
Inotropes and vasopressorspankaj rana
 
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdf
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdfANS-_Adrenergic_drugs-alpha__beta_agonists.pdf
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdfSanjayaManiDixit
 
inotropic drugs and vassopressors drugs.pptx
inotropic drugs and vassopressors drugs.pptxinotropic drugs and vassopressors drugs.pptx
inotropic drugs and vassopressors drugs.pptxAhmed638947
 
Ch 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCh 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCMBurr43
 

Similaire à Practical pharmacology CNS (20)

Adrenergic drugs (VK)
Adrenergic drugs (VK)Adrenergic drugs (VK)
Adrenergic drugs (VK)
 
Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptx
 
SYMPATHOMIMETICS AND LYTICS .pptx
SYMPATHOMIMETICS AND LYTICS .pptxSYMPATHOMIMETICS AND LYTICS .pptx
SYMPATHOMIMETICS AND LYTICS .pptx
 
INOTROPES IN SHOCK.pptx
INOTROPES IN SHOCK.pptxINOTROPES IN SHOCK.pptx
INOTROPES IN SHOCK.pptx
 
7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt
 
Vasoactive and inotropic agents
Vasoactive and inotropic agentsVasoactive and inotropic agents
Vasoactive and inotropic agents
 
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. PawanPharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
 
adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonists
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptx
 
ANS Pharmacology- Adrenergic Drugs
ANS Pharmacology- Adrenergic DrugsANS Pharmacology- Adrenergic Drugs
ANS Pharmacology- Adrenergic Drugs
 
Adrenergic (l)
Adrenergic (l)Adrenergic (l)
Adrenergic (l)
 
Inotropes and vasopressors
Inotropes and vasopressorsInotropes and vasopressors
Inotropes and vasopressors
 
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdf
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdfANS-_Adrenergic_drugs-alpha__beta_agonists.pdf
ANS-_Adrenergic_drugs-alpha__beta_agonists.pdf
 
Adrenal agonist
Adrenal agonistAdrenal agonist
Adrenal agonist
 
Adrenal agonist agents
Adrenal agonist agentsAdrenal agonist agents
Adrenal agonist agents
 
L5 ans pharmacology 17 18
L5 ans pharmacology 17 18L5 ans pharmacology 17 18
L5 ans pharmacology 17 18
 
inotropic drugs and vassopressors drugs.pptx
inotropic drugs and vassopressors drugs.pptxinotropic drugs and vassopressors drugs.pptx
inotropic drugs and vassopressors drugs.pptx
 
Ch 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCh 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharm
 
L6: adrenergic neurotransmition/ agonists
L6: adrenergic neurotransmition/ agonistsL6: adrenergic neurotransmition/ agonists
L6: adrenergic neurotransmition/ agonists
 

Dernier

CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 

Dernier (20)

CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 

Practical pharmacology CNS

  • 1. 2ND YEAR MEDICAL STUDENTS MODULE IX BY DR. HAZEM ABO SHOUSHA
  • 2. Main rules •ABP: pressure of blood on arterial wall
  • 3. ABP= COP X PVR COP= HR X SV Main rules
  • 5. Main rules β1 Agonist M2 blocker β1 blocker M2 agonist HEART RATE
  • 7. Main rules BLOOD PRESSURE (Bl.V) VC α1 agonist β2 blocker VD α1 blocker β2 agonist M3 agonist
  • 10.
  • 11. Observation: increased ABP with minimal effect on HR, which increases only with high doses Explanation of effect of NE on ABP & HR:  NE acts mainly on 1 receptors  vasoconstriction PVR  With higher doses of NE, it activates also cardiac 1 receptors some increase in the heart rate
  • 13.
  • 14. What is the effect of Prazosin on ABP and HR? •it blocks 1 adrenoceptors  vasodilationPVRABP •ABP slight reflex tachycardia
  • 15. Noradrenaline cause very minimal  in HR  β1 stimulation minimal  in BP
  • 17.
  • 18. Observation:  ABP & HR late The ABP  before returning to base line level Explanation of the effect of epinephrine on HR & ABP Epinephrine stimulates 1 , 1, 2 adrenoceptors Beta receptors are more sensitive to the effect of epinephrine On heart: 1 activation  +ve inotropic & chronotropic effects  COP leading to increased ABP On BV : - 1 activation vasoconstriction  PVR. - 2 activation vasodilatation  PVR
  • 19. •The net effect of these two opposing effects (1 & 2 ) on bl.v is an in  PVR (1 wins at 1st ) •At High concentration: EPI stimulates 1 •At Low concentration: EPI stimulates 2
  • 20. AdrenalineNoradrenalineparameters More increaseMild or no increaseHeart rate Less increase than noradrenaline More increaseBlood pressure BP decreases before reaching base line Reach base line directlyBP before Base line
  • 22.
  • 23. Observation: blocking 1 receptors by atenolol blocks the effect of epinephrine on HR & decreases the effect on ABP
  • 24. block alpha1 & beta1 receptors & then inject epinephrine
  • 25. EPINEPHRINE REVERSAL: The presser effect of epinephrine is reversed due to 1 & 1 blockade, leaving the 2 vasodilating effect acting   ABP
  • 26. β1 + β2 blocker Non-selective beta blocker PROPRANOLOL
  • 27. How to confirm the cause of epinephrine reversal? No epinephrine reversal since propranolol blocks not only cardiac 1 receptors but also vascular 2 receptors
  • 28. What is the effect of propranolol on ABP and HR?
  • 29. Propranolol mechanism as antihypertensive: 1-Block β1 in heart so low COP BP 2-  central sympathetic discharge  BP 3- Block β1 in kidney Renin  BP 4- resetting of Baroreceptors  BP 5- Block β2 presynaptic NE release  BP
  • 30. β1 + β2 agonist Non-selective beta agonist ISOPRENALINE
  • 31.
  • 32. Observation: • Isoprenaline increases HR • Isoprenaline initially decreases ABP. • As HR reaches its maximum increase, ABP shows minimal increase before returning to normal Explanation for the effect of isoprenaline on HR & ABP • Isoprenaline activates mainly beta adrenoceptor • It activates cardiac 1 receptors leading to increase in HR & force of contraction (which increases COP) • Activation of 2 receptors—Vasodilation decrease in PVR • The net effect of the two factors (COP & PVR) is a decrease in blood pressure initially. • However, when force of contraction is markedly elevated, the increase of COP overcomes the effect of decrease in PVR and thus ABP starts to increase.
  • 33. Design an experiment to prove the explanation for the effect of Isoprenaline on HR & ABP
  • 34. Observation: atenolol abolishes the effect of isoprenaline on HR The initial ABP-lowering effect of isoprenaline is maintained, while its pressor effect is abolished
  • 35. PROPRANOLOL FOLLOWED BY ISOPRENALINE Observation: Propranolol blocks 1 & 2 receptors thus abolishes the effect of isoprenaline on ABP
  • 36. 1 agonist selective Alpha agonist PHENYLEPHRINE
  • 37. Observation: Small dose phenylephrine leads to slight increase in ABP with no effect on HR High dose phenylephrine increases markedly ABP with decrease in the HR ( reflex bradycardia)
  • 38. Explanation of the effect of phenylephrine on ABP & HR •Activation of 1 receptors  vasoconstrictionPVR •High dose of phenylephrine  marked elevation of ABP  reflex  in sympathetic activity. Parasympathetic activity will take the upper hand  HR
  • 39. prove the explanation of the effect of phenylephrine on HR and ABP Observation: prazosin abolishes the effect of phenylephrine on ABP & reflex bradycardia disappears
  • 40. prove that reflex bradycardia is due to relative increase in parasympathetic activity Observation: decreased HR is abolished by atropine despite of elevation of ABP
  • 41. Nicotinic Nn , Nm ACETYLCHOLINE ( Ach ) Muscarinic M1 , M2 ,M3
  • 42.
  • 43. Observation: small doses of acetylcholine lower only ABP Higher doses produce both  in the HR & more significant lowering of ABP Explanation for the effect of acetylcholine on HR and ABP •on heart: M2 activation  - ve chronotropic effect  COP •on BV: endothelial cells M3 activation  release of NO from vascular endothelial cells  vasodilatation  PVR • Decrease in heart rate & decrease in PVR lead to  ABP
  • 44. Inject ATROPINE & then test the effect of ACETYLCHOLINE
  • 45. ACETYLCHOLINE REVERSAL 1. Inject a test dose of Ach 2. Inject atropine 3.Inject the same dose of acetylcholine 4.Inject a dose of Ach which is 10 times the test dose
  • 46. Explanation for acetylcholine reversal • Atropine injection  A parasympatholytic blocks muscarinic receptors. It blocks the effect of small dose of Ach. • Ach injection [big dose]  Stimulates nicotinic receptors Nn after muscarinic receptors have been blocked by atropine   ABP • Due to activation of Nn at : • Adrenal medulla  release epinephrine  BP • Autonomic ganglia  release of catecholamines from post-synaptic adrenergic nerve endings  BP • The BP by Ach [big dose] after muscarinic receptor block [by atropine]  Ach reversal
  • 47. oAch reversal by : Nn receptors oEPI reversal by : β2 receptors
  • 48. Reversible anticholinesterase So  Ach ‘ ’augment Ach effect ‘ ’ NEOSTIGMINE
  • 49. prove the mechanism of action of neostigmine